Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO) (HX959036)

Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHX959036
Descripción
Alnuctamab (HX959036) is a research-grade recombinant antibody targeting CD269. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FCM, Functional assay, Research in vivo
Especie huéspedHuman
ClonalidadMonoclonal
IsotipoIgG1;IgG1, Kappa;Lambda
Objetivo B-cell maturation protein, BCM, BCMA, CD269, TNFRSF17, Tumor necrosis factor receptor superfamily member 17, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E
Nivel de endotoxinas < 10 EU/mg
Pureza >95% as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso Q02223 & P07766
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativosTrivalentBispecific, CC-93269, EM-901, 2296827-07-9
FondoTeclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma
Nota For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Human IgG1 (E356D/M358L), kappa Recombinant Isotype Control Antibody (HyHEL-10) (HV080013)
Anti-LASV GPC Recombinant Antibody (Fab 37.7) (VK453013)
Imágenes
  • Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

    Bioactivity

    Detects Human CD269/TNFRSF17/BCMA in indirect ELISAs.

  • Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

    SDS-PAGE

    SDS-PAGE for Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores